Invention Application
- Patent Title: ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE
-
Application No.: US15363786Application Date: 2016-11-29
-
Publication No.: US20170151344A1Publication Date: 2017-06-01
- Inventor: Kurt C. GISH , Jonathan A. Hickson , Susan Elizabeth Morgan-Lappe , James W. Purcell
- Applicant: AbbVie Inc. , AbbVie Biotherapeutics Inc.
- Main IPC: A61K47/48
- IPC: A61K47/48 ; A61K38/07 ; A61K31/5517 ; C07K16/30

Abstract:
The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
Public/Granted literature
- US10195209B2 Anti-huLRRC15 antibody drug conjugates and methods for their use Public/Granted day:2019-02-05
Information query